Skip to content

Clinical outcomes of customized corneal cross-linking for progressive pellucid marginal degeneration.

Clinical outcomes of customized corneal cross-linking for progressive pellucid marginal degeneration. - Clinical outcomes of customizedCXL for progressive PMD.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044361
Enrollment
30
Registered
2021-05-28
Start date
2020-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

progressivePMD

Interventions

None listed

Sponsors

Kitasato university Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: progressivePMD

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
The subjects were 17 progressive PMD eyes (15 males and 2 females, age 43.4 years) who underwent Customized CXL at Kitasato University Hospital. The visual acuity, subjective refractive power, astigmatic power, and corneal refractive power before and after the operation were examined retrospectively.

Countries

Japan

Contacts

Public Contactmasahide takahashi

Kitasato university Hospital Ophthalmogogy

zavide96@gmail.com0427788111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026